Literature DB >> 15961818

Aspirin for everyone older than 50? For.

Peter Elwood1, Gareth Morgan, Ginevra Brown, Janet Pickering.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15961818      PMCID： PMC558385          DOI： 10.1136/bmj.330.7505.1440

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

Review 1.  Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

Authors:  Christine A Szekely; Jennifer E Thorne; Peter P Zandi; Mats Ek; Erick Messias; John C S Breitner; Steven N Goodman
Journal:  Neuroepidemiology       Date:  2004 Jul-Aug       Impact factor: 3.282

Review 2.  Mendelian randomization: prospects, potentials, and limitations.

Authors:  George Davey Smith; Shah Ebrahim
Journal:  Int J Epidemiol       Date:  2004-02       Impact factor: 7.196

3.  Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease.

Authors:  S Ebrahim; G D Smith
Journal:  BMJ       Date:  1997-06-07

4.  Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1984-09       Impact factor: 3.710

5.  Adverse drug events in ambulatory care.

Authors:  Tejal K Gandhi; Saul N Weingart; Joshua Borus; Andrew C Seger; Josh Peterson; Elisabeth Burdick; Diane L Seger; Kirstin Shu; Frank Federico; Lucian L Leape; David W Bates
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

6.  Cardiovascular disease risk profiles.

Authors:  K M Anderson; P M Odell; P W Wilson; W B Kannel
Journal:  Am Heart J       Date:  1991-01       Impact factor: 4.749

7.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

8.  A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

Authors:  P C Elwood; A L Cochrane; M L Burr; P M Sweetnam; G Williams; E Welsby; S J Hughes; R Renton
Journal:  Br Med J       Date:  1974-03-09

Review 9.  Epidemiology of non-steroidal anti-inflammatory drugs and cancer.

Authors:  John A Baron
Journal:  Prog Exp Tumor Res       Date:  2003

10.  Evidence for colorectal cancer cell specificity of aspirin effects on NF kappa B signalling and apoptosis.

Authors:  F V N Din; M G Dunlop; L A Stark
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640
View more
  11 in total

1.  [Acetylsalicylic acid protects against solid tumors].

Authors:  J R Izbicki; B T Hofmann; S Nitschmann
Journal:  Internist (Berl)       Date:  2012-02       Impact factor: 0.743

2.  Aspirin for everyone over 50? The buck stops in the consulting room.

Authors:  Arunachalam Kumar
Journal:  BMJ       Date:  2005-07-16

3.  Aspirin for everyone over 50? Are we treating a nutritional deficiency?

Authors:  Michael McMullen
Journal:  BMJ       Date:  2005-07-16

4.  Aspirin for everyone over 50? Avoid the harm.

Authors:  Lexley M Pinto Pereira
Journal:  BMJ       Date:  2005-07-16

5.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Per Olav Vandvik; A Michael Lincoff; Joel M Gore; David D Gutterman; Frank A Sonnenberg; Pablo Alonso-Coello; Elie A Akl; Maarten G Lansberg; Gordon H Guyatt; Frederick A Spencer
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

6.  General method for the synthesis of salicylic acids from phenols through palladium-catalyzed silanol-directed C-H carboxylation.

Authors:  Yang Wang; Vladimir Gevorgyan
Journal:  Angew Chem Int Ed Engl       Date:  2015-01-19       Impact factor: 15.336

7.  Aspirin for everyone over 50? Don't forget aspirin resistance.

Authors:  Ketan K Dhatariya
Journal:  BMJ       Date:  2005-07-16

8.  Potential contribution of aspirin to cancer control programmes.

Authors:  G Morgan
Journal:  Ecancermedicalscience       Date:  2008-11-12

9.  Prophylactic Aspirin and Public.

Authors:  Gareth Morgan
Journal:  AIMS Public Health       Date:  2013-10-31

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.